+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Dow posts best monthly gain since 1987 on continued vaccine optimism

Dec 1, 2020, 04:02 IST
Business Insider
Xinhua/Wang Ying/ Getty Images
  • US stocks declined on Monday. But the Dow Jones industrial average's 11.8% rise in November represented its best monthly gain since January 1987.
  • Investor optimism about a COVID-19 vaccine continued on Monday after Moderna said it would file for emergency use authorization from the Food and Drug Administration for its vaccine.
  • In November, Pfizer, Moderna, and AstraZeneca reported vaccine efficacy data well above the 50% threshold set by the FDA.
  • Watch major indexes update live here.
Advertisement

The Dow Jones industrial average finished November on a down note on Monday, but the index still managed to notch its best monthly gain in nearly 34 years.

The Dow finished the month having climbed by 11.8%, ahead of April's strong 11.1% gain but below the 13.8% monthly gain in January 1987.

November's strong rally was mostly driven by continued optimism about a COVID-19 vaccine, as Moderna, Pfizer, and AstraZeneca reported efficacy rates that surpassed the Food and Drug Administration's threshold of 50%.

On Monday, Moderna said it would submit data from its phase-three trial to the FDA to be considered for an emergency use authorization. Investors remain optimistic that a successful COVID-19 vaccine will help jump-start a swift economic reopening in 2021.

Here's where US indexes stood at the 4 p.m. ET close on Monday:

Advertisement

Read more: Buy these 10 stocks set to soar and smash Wall Street's expectations in the recovery from COVID-19, RBC says

Nikola plunged as much as 28% after it announced a revised deal with General Motors that failed to include an equity investment from GM and a commitment to develop and manufacture Nikola's Badger pickup truck. But JPMorgan defended Nikola and called the decline a good buying opportunity.

S&P Global said it would acquire IHS Markit in an all-stock deal worth $44 billion. IHS Markit traded up as much as 7% as investors cheered a merger of two data providers.

DoorDash and Airbnb remain on the path to go public by the end of this year, as they both seek increased valuation debuts in a surging stock market. A filing on Monday said DoorDash was aiming for a valuation of up to $27 billion, with proceeds of roughly $2.8 billion.

Read more: Cheap stocks just had their best month ever. A Wall Street expert breaks down why their outperformance is bound to continue over the next 4 to 5 years — and listed 2 bargain stocks to buy to capitalize on the trend.

Advertisement

Pending home sales fell in the US for the second straight month as a continued surge in home prices dented housing markets' rally.

Oil prices fell. West Texas Intermediate crude dropped as much as 2.4%, to $44.42 per barrel. Brent crude, oil's international benchmark, declined 2.8%, to $46.85 per barrel, at intraday lows.

Gold declined as much as 1.3%, to $1,764.80 per ounce.

Read more: GOLDMAN SACHS: Buy these 16 stocks that are underestimated for now, but should crush expectations in 2021-22 on the way to at least 20% upside

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article